JP2024534947A5 - - Google Patents
Info
- Publication number
- JP2024534947A5 JP2024534947A5 JP2024515041A JP2024515041A JP2024534947A5 JP 2024534947 A5 JP2024534947 A5 JP 2024534947A5 JP 2024515041 A JP2024515041 A JP 2024515041A JP 2024515041 A JP2024515041 A JP 2024515041A JP 2024534947 A5 JP2024534947 A5 JP 2024534947A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- liquid pharmaceutical
- use according
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21197120.5 | 2021-09-16 | ||
| EP21197120 | 2021-09-16 | ||
| PCT/EP2022/075402 WO2023041524A2 (en) | 2021-09-16 | 2022-09-13 | Compositions and methods for treating synucleinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534947A JP2024534947A (ja) | 2024-09-26 |
| JP2024534947A5 true JP2024534947A5 (cg-RX-API-DMAC7.html) | 2025-09-05 |
Family
ID=78049153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515041A Pending JP2024534947A (ja) | 2021-09-16 | 2022-09-13 | シヌクレイノパチーを治療するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US12077578B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4401770A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534947A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240055758A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117915952A (cg-RX-API-DMAC7.html) |
| AR (1) | AR127054A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022348798A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230055A1 (cg-RX-API-DMAC7.html) |
| CL (2) | CL2024000753A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311344A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002970A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023041524A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019114679A (ru) * | 2016-11-15 | 2020-12-17 | Х. Лундбекк А/С | Средства, пути применения и способы лечения синуклеопатии |
| IL311344A (en) | 2021-09-16 | 2024-05-01 | H Lundbeck As | Preparations and methods for the treatment of synoclinopathies |
| IL326387A (en) * | 2023-09-14 | 2026-04-01 | Hoffmann La Roche | Antibody formulation |
| WO2025186235A1 (en) | 2024-03-05 | 2025-09-12 | H. Lundbeck A/S | Compositions and methods for treating multiple system atrophy (msa) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2361928T3 (en) * | 2003-05-19 | 2017-07-03 | Prothena Biosciences Ltd | Truncated fragments of alpha synuclein in Lewy body disease |
| US10513555B2 (en) * | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| GB201512203D0 (en) | 2015-07-13 | 2015-08-19 | Lundbeck & Co As H | Agents,uses and methods |
| WO2017176835A2 (en) * | 2016-04-06 | 2017-10-12 | Imago Pharmaceuticals, Inc. | Therapeutic antibodies for treatment of neurodegeneration |
| RU2019114679A (ru) * | 2016-11-15 | 2020-12-17 | Х. Лундбекк А/С | Средства, пути применения и способы лечения синуклеопатии |
| JOP20190227A1 (ar) * | 2017-03-31 | 2019-09-30 | Biogen Int Neuroscience Gmbh | تركيبات وطرق لعلاج اعتلالات السينوكلين |
| IL311344A (en) | 2021-09-16 | 2024-05-01 | H Lundbeck As | Preparations and methods for the treatment of synoclinopathies |
-
2022
- 2022-09-13 IL IL311344A patent/IL311344A/en unknown
- 2022-09-13 CA CA3230055A patent/CA3230055A1/en active Pending
- 2022-09-13 JP JP2024515041A patent/JP2024534947A/ja active Pending
- 2022-09-13 CN CN202280060631.5A patent/CN117915952A/zh active Pending
- 2022-09-13 WO PCT/EP2022/075402 patent/WO2023041524A2/en not_active Ceased
- 2022-09-13 MX MX2024002970A patent/MX2024002970A/es unknown
- 2022-09-13 KR KR1020247008828A patent/KR20240055758A/ko active Pending
- 2022-09-13 EP EP22789489.6A patent/EP4401770A2/en active Pending
- 2022-09-13 AU AU2022348798A patent/AU2022348798A1/en active Pending
- 2022-09-13 AR ARP220102483A patent/AR127054A1/es unknown
-
2023
- 2023-06-26 US US18/341,437 patent/US12077578B2/en active Active
-
2024
- 2024-03-13 CL CL2024000753A patent/CL2024000753A1/es unknown
- 2024-07-15 US US18/773,301 patent/US20250084156A1/en active Pending
- 2024-07-16 US US18/774,629 patent/US12351624B2/en active Active
- 2024-07-16 US US18/774,646 patent/US12358975B2/en active Active
- 2024-07-16 US US18/774,608 patent/US12358974B2/en active Active
- 2024-12-03 CL CL2024003713A patent/CL2024003713A1/es unknown
-
2025
- 2025-12-22 US US19/429,170 patent/US20260217807A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7080263B2 (ja) | 高濃度の抗vegf抗体を含有する安定状態のタンパク質溶液製剤 | |
| US20230047111A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| JP2024099682A5 (cg-RX-API-DMAC7.html) | ||
| JP2020506924A5 (cg-RX-API-DMAC7.html) | ||
| IL311344A (en) | Preparations and methods for the treatment of synoclinopathies | |
| JP2017160208A5 (cg-RX-API-DMAC7.html) | ||
| CN106061468B (zh) | 包含TNFR和Fc区的融合蛋白的液体制剂 | |
| TWI857996B (zh) | 含高濃度抗vegf抗體之蛋白質溶液配製物 | |
| RU2018107725A (ru) | Стабильный состав на основе антитела к ifnar1 | |
| FI3576788T3 (fi) | Matalan ph-arvon omaava farmaseuttinen koostumus, joka käsittää t-soluihin sitoutuvia vasta-ainekonstrukteja | |
| JP7398958B2 (ja) | 安定的抗osmr抗体製剤 | |
| JP2022513684A5 (cg-RX-API-DMAC7.html) | ||
| US20250073170A1 (en) | High concentration formulations of anti-csf1 and anti-csf1r antibodies | |
| JP2020510079A (ja) | 抗TNFα抗体の液状製剤 | |
| JP2015535237A (ja) | Tnfr:fc融合プロテインの安定な医薬組成物 | |
| JP2018531980A (ja) | 抗d因子抗体製剤 | |
| JP2018532693A5 (cg-RX-API-DMAC7.html) | ||
| JP2018536650A5 (cg-RX-API-DMAC7.html) | ||
| JP2018501311A (ja) | 液体医薬組成物 | |
| RU2024106395A (ru) | Композиции и способы для лечения синуклеинопатий | |
| TWI775827B (zh) | 水性製劑及裝入注射器之水性製劑以及抗體蛋白去凝集劑及抗體蛋白去凝集方法 | |
| JP2025515205A5 (cg-RX-API-DMAC7.html) | ||
| US20250215086A1 (en) | Anti-pd-1 antibody formulations | |
| TWI887362B (zh) | 抗內皮脂肪酶抗體之配製物 | |
| JP2023514721A5 (cg-RX-API-DMAC7.html) |